DanCann Pharma Company Description

DanCann Pharma A/S, a biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas.

It sources, develops, and distributes prescription and over-the-counter cannabinoid-based pharmaceuticals primarily focused on pain patients.

The company’s development pipeline includes EXT02 CannGros, EXT03 CannGros, EXT04 CannGros, FLS04 CannGros, and FLS05 CannGros.

It is also involved in the import and distribution of Bedrocan CannGros, Bedica CannGros, and Bediol CannGros.

The company was incorporated in 2018 and is based in Ansager, Denmark.

DanCann Pharma A/S

Country	Denmark
Founded	2018
Industry	Pharmaceutical Preparations
Employees	12
CEO	Jeppe Rasmussen

Contact Details

Address: Rugvænget 5 Ansager, 6823 Denmark
Phone	45 69 16 03 93
Website	dancann.com

Stock Details

Ticker Symbol	DANCAN
Exchange	Nordic Growth Market
Fiscal Year	January - December
Reporting Currency	DKK
SIC Code	2834

Key Executives

Name	Position
Jeppe Rasmussen	Chief Executive Officer
Peter Sondergaard	Chief Financial Officer